Skip to main content
ZJAMP Group Co., Ltd. logo

ZJAMP Group Co., Ltd. — Investor Relations & Filings

Ticker · 002758 ISIN · CNE100002029 LEI · 3003009OKT32LB5C0T64 Shenzhen Stock Exchange Wholesale and retail trade
Filings indexed 1,563 across all filing types
Latest filing 2018-06-22 Board/Management Inform…
Country CN China
Listing Shenzhen Stock Exchange 002758

About ZJAMP Group Co., Ltd.

https://www.znjtgf.com

ZJAMP Group Co., Ltd. specializes in the comprehensive distribution and supply chain management of agricultural production materials. The company’s core operations encompass the procurement, storage, and sale of essential inputs, including chemical fertilizers such as urea, potash, and compound fertilizers, as well as pesticides, seeds, and agricultural machinery. Beyond product distribution, the organization provides integrated technical services, modern logistics solutions, and agricultural consultancy to enhance crop yields and farming efficiency. By leveraging an extensive network of distribution centers and service stations, the group facilitates the stable supply of high-quality agricultural resources. Its business model focuses on bridging the gap between manufacturers and end-users through efficient resource allocation and value-added services.

Recent filings

Filing Released Lang Actions
第三届董事会第十四次会议决议公告
Board/Management Information Classification · 95% confidence The document is a formal announcement of resolutions passed at a board meeting of Zhejiang Huatong Pharmaceutical Co., Ltd. It details the convening of the third board's 14th meeting, the voting results on specific proposals related to convertible bond issuance and related regulatory compliance. The content focuses on board decisions and procedural compliance, with no financial statements or earnings data. The document length is short (1166 characters), and it is clearly a board meeting resolution announcement rather than a full report or financial filing. Therefore, it fits best under 'Board/Management Information' (MANG), which covers announcements of changes or decisions by the board or senior management.
2018-06-22 Chinese
关于全资子公司取得药品GMP证书的公告
Regulatory Filings Classification · 95% confidence The document is a short announcement from Zhejiang Huatong Pharmaceutical Co., Ltd. about its wholly-owned subsidiary obtaining a drug GMP certificate issued by the Zhejiang Food and Drug Administration. It contains no financial data, no report or financial statements, and is primarily an official regulatory announcement about certification. The document length is only 548 characters, indicating it is a brief announcement rather than a full report. It does not fit into categories like Annual Report, Interim Report, or Earnings Release. It is best classified as a Regulatory Filing (RNS), which covers general regulatory announcements and compliance documents that do not fit other categories.
2018-06-21 Chinese
公开发行可转换公司债券发行结果公告
Capital/Financing Update Classification · 100% confidence The document is an announcement regarding the issuance results of convertible bonds by Zhejiang Huatong Pharmaceutical Co., Ltd. It details the bond issuance scale, subscription results by original shareholders and public investors, underwriting by the lead underwriter, and related procedural information. The content focuses on capital raising activities and the outcome of the bond issuance, without containing financial statements or detailed financial performance data. The document length is relatively short (1627 characters) and it is clearly an announcement of financing results rather than a full financial report. Therefore, the appropriate classification is Capital/Financing Update (CAP).
2018-06-20 Chinese
公开发行可转换公司债券网上中签结果公告
Capital/Financing Update Classification · 95% confidence The document is an announcement regarding the results of the online lottery for the subscription of convertible bonds issued by Zhejiang Huatong Pharmaceutical Co., Ltd. It details the subscription process, the obligations of investors, underwriting arrangements, and the lottery results for bond allocation. The document does not contain financial statements or detailed financial analysis but rather provides information about the issuance and allocation of convertible bonds. This fits the category of a Capital/Financing Update, as it relates to the company's fundraising activity through convertible bond issuance.
2018-06-18 Chinese
公开发行可转换公司债券网上中签率及优先配售结果公告
Capital/Financing Update Classification · 95% confidence The document is an announcement regarding the results of the public issuance of convertible bonds by Zhejiang Huatong Pharmaceutical Co., Ltd. It details the subscription results, allocation, and related procedural information about the convertible bond issuance. It references regulatory rules and issuance procedures but does not contain financial statements or detailed financial performance data. The document is relatively short (3077 characters) and serves as a formal announcement of the subscription and allocation results for the convertible bonds, not a full financial report or prospectus. Therefore, it fits best into the category of Capital/Financing Update (CAP), which covers updates on company fundraising and financing activities.
2018-06-14 Chinese
公开发行可转换公司债券发行方案提示性公告
Capital/Financing Update Classification · 95% confidence The document is a detailed announcement regarding the public issuance of convertible bonds by Zhejiang Huatong Pharmaceutical Co., Ltd. It includes specifics about the issuance plan, subscription dates, subscription rules, underwriting arrangements, and regulatory approvals. The text references regulatory frameworks and provides detailed procedural information about the bond issuance, including subscription codes, allotment rules, and investor obligations. It does not contain financial statements, audit opinions, or management discussions typical of annual or interim reports. It is not a transcript, nor a voting result announcement, nor a remuneration or governance report. The document is a formal announcement of a capital raising activity through convertible bond issuance, which fits the category of Capital/Financing Update (CAP). The document length is over 6,000 characters and contains substantive details about the financing event, not merely a brief notice or a report publication announcement.
2018-06-13 Chinese

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.